Gesesew H, Ward P, Woldemichael K, Lyon P, Mwanri L
Health Expect. 2020; 23(5):1326-1337.
PMID: 32761685
PMC: 7696206.
DOI: 10.1111/hex.13115.
Gesesew H, Ward P, Woldemichael K, Mwanri L
Int J Environ Res Public Health. 2020; 17(1).
PMID: 31935963
PMC: 6982005.
DOI: 10.3390/ijerph17010378.
Okoboi S, Ding E, Persuad S, Wangisi J, Birungi J, Shurgold S
AIDS Res Ther. 2015; 12:37.
PMID: 26566390
PMC: 4642676.
DOI: 10.1186/s12981-015-0077-4.
Mori A, Owenya J
J Pharm Policy Pract. 2015; 7:3.
PMID: 25848543
PMC: 4366935.
DOI: 10.1186/2052-3211-7-3.
Janssen S, Huson M, Belard S, Stolp S, Kapata N, Bates M
Infection. 2013; 42(2):281-94.
PMID: 24311148
DOI: 10.1007/s15010-013-0568-y.
Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.
Bekolo C, Webster J, Batenganya M, Sume G, Kollo B
BMC Res Notes. 2013; 6:512.
PMID: 24308609
PMC: 3937159.
DOI: 10.1186/1756-0500-6-512.
Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: a retrospective cohort study.
Poka-Mayap V, Pefura-Yone E, Kengne A, Kuaban C
BMJ Open. 2013; 3(7).
PMID: 23852140
PMC: 3710986.
DOI: 10.1136/bmjopen-2013-003210.
Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique.
Shepherd B, Blevins M, Vaz L, Moon T, Kipp A, Jose E
Am J Epidemiol. 2013; 178(5):819-28.
PMID: 23785113
PMC: 3755641.
DOI: 10.1093/aje/kwt030.
Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.
McMahon J, Elliott J, Hong S, Bertagnolio S, Jordan M
PLoS One. 2013; 8(2):e56047.
PMID: 23424643
PMC: 3570556.
DOI: 10.1371/journal.pone.0056047.
Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial.
Mbuagbaw L, Thabane L, Ongolo-Zogo P, Yondo D, Noorduyn S, Smieja M
AIDS Res Ther. 2012; 9(1):37.
PMID: 23253095
PMC: 3537690.
DOI: 10.1186/1742-6405-9-37.
Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study.
Oliveira I, Andersen A, Furtado A, Medina C, Da Silva D, da Silva Z
BMJ Open. 2012; 2(6).
PMID: 23151393
PMC: 3532999.
DOI: 10.1136/bmjopen-2012-001587.
Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria.
Onoka C, Uzochukwu B, Onwujekwe O, Chukwuka C, Ilozumba J, Onyedum C
Pathog Glob Health. 2012; 106(1):46-54.
PMID: 22595274
PMC: 4001511.
DOI: 10.1179/2047773211Y.0000000018.
Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study.
Unge C, Sodergard B, Marrone G, Thorson A, Lukhwaro A, Carter J
PLoS One. 2010; 5(10):e13613.
PMID: 21049045
PMC: 2963610.
DOI: 10.1371/journal.pone.0013613.
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.
Nicholson O, DiCandilo F, Kublin J, Sun X, Quirk E, Miller M
AIDS Res Hum Retroviruses. 2010; 27(5):557-567.
PMID: 20854108
PMC: 3422055.
DOI: 10.1089/AID.2010.0151.
Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?.
Veenstra N, Whiteside A, Lalloo D, Gibbs A
Global Health. 2010; 6:4.
PMID: 20356383
PMC: 2859818.
DOI: 10.1186/1744-8603-6-4.
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
Losina E, Toure H, Uhler L, Anglaret X, Paltiel A, Balestre E
PLoS Med. 2009; 6(10):e1000173.
PMID: 19859538
PMC: 2762030.
DOI: 10.1371/journal.pmed.1000173.
Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.
Rougemont M, Stoll B, Elia N, Ngang P
AIDS Res Ther. 2009; 6:21.
PMID: 19821997
PMC: 2770068.
DOI: 10.1186/1742-6405-6-21.
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.
Rosen S, Fox M, Gill C
PLoS Med. 2007; 4(10):e298.
PMID: 17941716
PMC: 2020494.
DOI: 10.1371/journal.pmed.0040298.
Antiretroviral drug resistance and routine therapy, Cameroon.
Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N
Emerg Infect Dis. 2006; 12(6):1001-4.
PMID: 16707062
PMC: 3298273.
DOI: 10.3201/eid1206.050860.